- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Abivax SA ADR (ABVX)
Assess today's live Abivax SA ADR (ABVX) share price, performance and insights using our live NASDAQ: ABVX stock exchange data.
Analyse the historical data and Abivax SA ADR share price performance charts on this page. Our technical summary section provides analysis on Abivax ADR share price buy/sell indicators using real-time data (or discuss the Abivax ADR (ABVX) stock price today with other investors in the Abivax ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ABVX share price (ISIN: US00370M1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Abivax SA ADR Share Price Today?
The Abivax ADR share price today is 124.99.
What Is the Stock Symbol for Abivax SA ADR
The stock symbol (or 'ticker') for Abivax SA ADR is "ABVX."
What Stock Exchange Does Abivax SA ADR Trade On?
Abivax SA ADR is listed and trades on the NASDAQ stock exchange.
Is Abivax SA ADR a Good Stock to Buy?
Determining whether Abivax SA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Abivax SA ADR share price performance charts on this page. Our technical summary section provides analysis on Abivax ADR share price buy/sell indicators using real-time data (or discuss the Abivax ADR (ABVX) stock price today with other investors in the Abivax ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ ABVX share price (ISIN: US00370M1036) to enhance your trading decisions with our free investment tools and resources.
What Is the Abivax SA ADR Share Price Today?
The Abivax ADR share price today is 124.99.
What Is the Stock Symbol for Abivax SA ADR
The stock symbol (or 'ticker') for Abivax SA ADR is "ABVX."
What Stock Exchange Does Abivax SA ADR Trade On?
Abivax SA ADR is listed and trades on the NASDAQ stock exchange.
Is Abivax SA ADR a Good Stock to Buy?
Determining whether Abivax SA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
123.01
126.25
52 wk Range
4.77
148.83
ABVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
123.01126.25
52 wk Range
4.77148.83
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockABVX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
152.90
Upside
+22.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
- Form 13D/A Abivax S.A. For: 14 January
- Investing.com
- Form 13D/A Abivax S.A. For: 14 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Abivax ADR Company Profile
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Compare ABVX to Peers and Sector
Metrics to compare | ABVX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABVXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.3x | −3.2x | −0.5x | |
PEG Ratio | 0.63 | 0.02 | 0.00 | |
Price/Book | 16.2x | 0.6x | 2.6x | |
Price / LTM Sales | 1,562.2x | 16.3x | 3.3x | |
Upside (Analyst Target) | 18.0% | 117.7% | 47.0% | |
Fair Value Upside | Unlock | 5.5% | 5.9% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 152.90
(+22.33% Upside)
Earnings
Latest Release
Dec 15, 2025
EPS / Forecast
-2.47 / -0.68
Revenue / Forecast
2.40M / --
People Also Watch
FAQ
What Is the Abivax ADR (ABVX) Share Price Today?
The live Abivax ADR share price today is 124.99
What Stock Exchange Does Abivax ADR (ABVX) Trade On?
Abivax ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Abivax ADR?
The stock symbol (also called a 'ticker') for Abivax ADR is "ABVX."
What Is the Current Abivax ADR Market Cap?
As of today, Abivax ADR market capitalisation is 9.82B.
What Is Abivax ADR's (ABVX) Earnings Per Share (TTM)?
The Abivax ADR EPS is currently -4.46 (Trailing Twelve Months).
When Is the Next Abivax ADR Earnings Date?
Abivax ADR's next earnings report will be released on 23/03/2026.
Is ABVX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Abivax ADR moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Abivax ADR Stock Split?
Abivax ADR has split 0 times. (See the ABVX stock split history page for full effective split date and price information.)
How Many Employees Does Abivax ADR Have?
Abivax ADR has 67 employees.
What is the current trading status of Abivax ADR (ABVX)?
As of 16/02/2026, Abivax ADR (ABVX) is trading at a price of 124.99, with a previous close of 124.54. The stock has fluctuated within a day range of 123.01 to 126.25, while its 52-week range spans from 4.77 to 148.83.
What Is Abivax ADR (ABVX) Price Target According to Analysts?
The average 12-month price target for Abivax ADR is USD152.90, with a high estimate of USD176 and a low estimate of USD131. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.33% Upside potential.
What Is the ABVX After Hours Price?
ABVX's last after hours stock price is 125.18, the stock has decreased by 0.19, or 0.15%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.